BIOMEM technology will revolutionise the bioprocessing industry by providing game-changing new technology, eliminating the current need for high-cost and high-energy downstream processes to remove biomass and salts.
This typically represents 70-90% of the cost of production of biochemical compounds, transforming the commercial viability of biobased production, including low-yield fermentation products.
This massive reduction in costs and energy consumption of biopharmaceuticals and bio-based products, together with a more circular economy and unpolluted environment, will deliver transformative benefits to EU citizens.
